Non-invasive Blood Pressure Monitors Market Size To Rise USD 51.21 Bn By 2032

The global non-invasive blood pressure monitors market size exceeded USD 28.09 billion in 2023 and is expected to rise to USD 51.21 billion by 2032, growing at a CAGR of 6.9% during the forecast period.

Market Overview

Non-invasive blood pressure (BP) measurement involves obtaining blood pressure readings without the need for invasive procedures. This method offers either intermittent or continuous monitoring. In intermittent non-invasive monitoring, a common approach involves using an occluding upper arm cuff. Blood pressure values are then obtained either manually through techniques such as auscultation of Korotkoff sounds or palpation, or automatically through automated devices.

These devices have gained popularity due to their non-invasive design and user-friendly features, eliminating the need for invasive procedures to measure blood pressure. They are crucial tools for healthcare professionals and individuals monitoring their blood pressure at home. The ease of use and non-invasive features contribute to the widespread adoption of these devices, enhancing their significance in both medical settings and personal health management.

The market for non-invasive blood pressure monitors has seen significant growth recently, propelled by a combination of factors. These devices, necessary for non-invasive blood pressure monitoring, have become popular in healthcare and household settings. One key factor contributing to this growth is the increase in the prevalence of hypertension, a global health concern. Moreover, the demand for these monitors has increased due to an ageing demographic, as older individuals often need frequent blood pressure monitoring.

Ongoing research, exemplified by innovations like the finger artery non-invasive tonooscillometric monitor (FANTOM) from the University of Turku, propels growth in the non-invasive blood pressure monitor market. For instance, using an oscillometric method, FANTOM, a tabletop device, utilises a tonometric cuffless mechatronic system to measure blood pressure on the fingertip. Its capabilities encompass measuring arterial waveforms and central blood pressure (CBP). Validated against an automated arm cuff monitor, FANTOM produced (0.9 7.3) mmHg results for SBP and (3.3 6.6) mmHg for DBP. For instance, these advancements in cuffless, non-invasive blood pressure monitors highlight the potential for market expansion in the forecast period.

Automated blood pressure readings demonstrate greater accuracy than traditional manual readings, especially among individuals with hypertension. The user-friendly nature and precision of digital BP monitors contribute to their increased acceptance. For instance, an article published under the title 'Self-Measured Blood Pressure Monitoring at Home: A Joint Policy Statement from the American Heart Association and American Medical Association' emphasizes the importance of self-measured BP monitoring in confirming the diagnosis of hypertension and assisting those with the condition in better blood pressure control. A BP monitor in every household is advocated due to the prevalence of heart-related issues.

The market is currently witnessing significant growth, propelled by the increasing prevalence of cardiovascular disorders, a rise in the obese population, and the adoption of unhealthy lifestyle habits. For instance, according to the World Health Organization (WHO), approximately 1.28 billion adults aged 30-79 worldwide suffer from hypertension, with the majority (two-thirds) residing in low- and middle-income countries. This trend is expected to persist and lead to substantial growth in the future demand for blood pressure monitoring devices.

  • On August 31, 2022, Sensifree LTD obtained a CE certificate for SentiCor-100, aligning with the new EU MDR. SentiCor-100, recognised as the world's first PPG-based Continuous Non-Invasive Blood Pressure (cNIBP) monitoring device, has received approval for hospital use.
  • In February 2022, InBody launched the BP 170 automatic blood pressure monitor, allowing individuals to record and monitor essential health metrics independently in the comfort of their homes.

Regional Snapshot

North America leads the non-invasive blood pressure monitors market. Technological advancements and increased health awareness also contribute to the region's market dominance due to its sizable elderly population prone to hypertension, well-established healthcare infrastructure, high healthcare spending, and a focus on preventive care, 

The rising incidence of hypertension and cardiovascular diseases is a significant health concern in the US. According to the Centers for Disease Control and Prevention, hypertension significantly increases the risk of heart disease and stroke, leading causes of death in the United States. In recent years, hypertension has contributed to over 670,000 deaths. Alarmingly, only about one in four adults (24%) have their hypertension under control, with approximately 37 million adults in the United States experiencing uncontrolled hypertension (45%), characterized by a blood pressure of 140/90 mmHg or higher.

Moreover, Government initiatives and awareness programs aimed at raising awareness and managing databases through remotely operated blood pressure monitors are anticipated to drive additional growth in the forecast period. One notable example is the national effort co-led by the Centers for Disease Control (CDS) and Prevention, the Million Hearts initiative, which strives to promote cardiovascular health. And the Centers for Medicare & Medicaid Services (CMS). Their priorities for 2027 include the goals of building healthy communities and optimizing care, with a dedicated focus on specific populations experiencing health inequities.

Non-invasive Blood Pressure Monitors Market Report Scope

Report Coverage Details
Market Revenue in 2023 USD 28.09 Billion
Projected Forecast Revenue by 2032 USD 51.29 Billion
Growth Rate from 2023 to 2032 CAGR of 6.9%
Largest Market North America
Base Year 2022
Forecast Period 2023 to 2032
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Key players' recent news/activity

  • In November 2023, GE Healthcare announced the validation of new data affirming the potential of Artificial Intelligence (AI) in forecasting patients' responses to immunotherapies before the commencement of their treatment.
  • In April 2022, Spacelabs Healthcare, an OSI Systems, Inc. division, revealed plans to showcase its latest diagnostic cardiology products at the 71st annual American College of Cardiology (ACC) event.

Market Dynamics


The widespread prevalence of hypertension, characterised by elevated blood pressure, significantly drives the growth of the non-invasive blood pressure monitor market. Hypertension is a prevalent health issue affecting a substantial portion of the global population and is a significant contributor to cardiovascular diseases, strokes, and other serious health complications. The increased incidence of hypertension has led to a substantial rise in the demand for blood pressure measurement devices, remarkably non-invasive models.

As awareness of the inherent risks linked with hypertension rises, more individuals are incorporating regular  BP  monitoring into their healthcare practices. This has led to a growing need for non-invasive monitors, attributed to their user-friendly nature, comfort, and accurate measurement capabilities. Solidifying these devices as essential components in hypertension management and proactive healthcare strategies, healthcare professionals are increasingly endorsing home blood pressure monitoring.


The growth of the non-invasive blood pressure measurement market will face obstacles due to certain drawbacks. Non-invasive blood pressure measurement exhibits less reliability at pressure extremes, and continuous monitoring becomes impractical. Additionally, frequent repetition can lead to discomfort, and for maximum accuracy, manual operation is required, as automatic modes prove unreliable in unstable patients. These factors are expected to restart market progress during the forecast period.


The growth of remote healthcare and telemedicine presents substantial opportunities in the non-invasive blood pressure monitor market. With the increasing emphasis on healthcare delivery through remote and virtual platforms, non-invasive blood pressure monitors play a crucial role for patients and healthcare providers. These devices enable individuals to monitor their blood pressure at home, thereby diminishing the necessity for frequent clinic visits. For instance, in January 2022, OMRON Healthcare, Inc. introduced remote patient monitoring services at CES, featuring connected blood pressure monitors and an advanced mobile app.

Research emphasises the importance of household blood pressure (BP) monitors for heart health. In the article, 'Self-Measured Blood Pressure Monitoring at Home: A Joint Policy Statement From the American Heart Association and American Medical Association,' self-monitoring is recognised for diagnosing and managing hypertension. This suggests potential investments in infrastructure to support expanded self-measured BP monitoring, covering patient and provider costs.

Recent Developments

  • In May 2023, ASUS announced today that its blood pressure applications for smartwatches were approved by Taiwan's Food and Drug Administration (TFDA) of the Ministry of Health and Welfare, obtaining a medical device software license from the Ministry of Health Medical Devices.
  • In April 2023, CardieX Limited (ASX: CDX) announced FDA clearance for its CONNEQT  Pulse arterial health monitor. It provides brachial and central blood pressure measurements and other vascular health biomarkers.
  • In August 2023, WhaleTeq introduced the BPA700 Non-invasive Blood Pressure Simulator & Analyzer, revolutionising BP monitor testing with unprecedented accuracy and versatility. The device reflects the medical industry's ongoing pursuit of advanced BP monitor testing.

Key Market Players

  • Omron Healthcare Welch Allyn, Inc.
  • A&D Medical Inc.
  • SunTech Medical, Inc.
  • American Diagnostics Corp.
  • Withings
  • Briggs Healthcare
  • GE Healthcare
  • Kaz Inc.
  • Microlife AG
  • Rossmax International Ltd.
  • GF Health Products Inc.
  • Spacelabs Healthcare Inc.
  • Philips Healthcare
  • Hill-Rom Services Inc.
  • Braun Healthcare
  • Contec
  • Biobeat 

Market Segmentation

By Device Type

  • Automated BP Monitors
  • Ambulatory BP Monitors
  • Sphygmomanometers
  • BP Transducers

By Technology

  • Digital
  • Aneroid
  • Wearable

By Accessory

  • Blood Pressure Cuffs
  • Manometers
  • Valves
  • Tubing
  • Bulb

By End-user

  • Hospitals
  • Clinics
  • Ambulatory Surgical Center
  • Home Care Setting
  • Others

Buy this Research Report@

You can place an order or ask any questions, please feel free to contact at | +1 650 460 3308